CX Interviews
CX 2024: Aortic Programme forefronts cutting-edge edited cases “on film” and multiple top-notch debates
Tilo Kölbel (vascular surgeon from Hamburg, Germany, and a member of the Executive Board for the Aortic Programme) makes the case for moving images that will "easily transport" vascular surgeons and interventionalists. He also has his eye [...]
CX 2024: Brand new data on cyanoacrylate glue, bioprosthetic valves and intensive pulmonary embolism treatments
Manj Gohel (Cambridge, UK) and member of the Venous Executive Board parachutes straight into the CX Venous and Lymphatics Controversies Programme to highlight the VenaSeal SPECTRUM programme, SAVVE trial and SYNCHRONOUS trial, which [...]
CX 2024: Get a ringside seat for the big BASIL-3 data reveal
No more freestyling, reset your endovascular CLTI practice with new Level 1 evidence Andrew Bradbury (Birmingham, UK) and the BASIL-3 team of triallists will be presenting, for the very first time, the results [...]
CX 2023: Reaching a Multidisciplinary Consensus
 In conversation with CX Chairman Professor Roger Greenhalgh, aortic expert Alexander Zimmerman (Zurich, Switzerland) discusses the upcoming Aortic course (Wednesday, 26 April), the importance of continuous education for the practicing surgeon and, a multidisciplinary approach to treating and managing the [...]
CX 2023: Innovation and Audience Interaction
Professor Andrew Holden (Auckland, New Zealand) is really excited about the 18 podium first presentations showcasing new data at CX 2023 and uniquely, the interaction between a world-class faculty and expert audience. Register now to attend CX 2023! [...]
CX 2023: Challenging the Vascular Status Quo
 In this conversation between CX chairman Roger Greenhalgh and Professor of Vascular Surgery, Maarit Venermo (Helsinki, Finland), we discuss the importance of challenging the status quo in vascular and endovascular surgery. Professor Venermo [...]